Spatial Proteomics in Drug Discovery and Clinical Research

Map protein expression in tissue context to accelerate drug discovery and clinical research.

Spatial proteomics refers to a class of analytical approaches that map protein expression directly within tissue architecture, providing biologically and clinically relevant insight into disease mechanisms and therapeutic response. Advances in spatial proteomic technologies have enabled researchers to understand cellular dynamics in healthy and diseased tissues with unparalleled depth and breadth. These capabilities have direct implications for drug discovery and development, enabling deeper understanding of disease biology, identification of novel and context-specific drug targets, and improved stratification of patients most likely to benefit from a given therapy.

In this application note from Leica, discover solutions that support spatial proteomics workflows across discovery, translational, and clinical research.

FILL THE FORM BELOW

First Name *

Last Name *

Company Street Address *

Company Suite/Office *

Company Postal/Zip Code *

Company City *

Company State *

Company Country *

By submitting this content request, I have legitimate interest in the content and agree that Leica Microsystems | Biocompare, their partners, and the creators of any other content I have selected may contact me regarding news, products, and services that may be of interest to me.

YesNo

Are you exploring spatial biology technologies for current or future research needs and open to discussing your workflow with a specialist?